NEW YORK & SEOUL, South Korea--(BUSINESS WIRE)--Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, and C&R Research (C&R), a leading South Korean full-service contract research organization (CRO), today announced that the Medidata Clinical Cloud® platform has been adopted to improve operational efficiencies, resource savings and decision-making processes across C&R’s entire R&D portfolio in Asia. As part of its company-wide initiative to achieve cutting-edge productivity, C&R is partnering with Medidata and leveraging its industry-leading electronic data capture and management technology, as well as the company’s best-in-class solution for risk-based monitoring (RBM)—a proven methodology for reducing trial costs while providing a higher level of clinical data accuracy and quality.
